vs

Side-by-side financial comparison of Greenland Technologies Holding Corp. (GTEC) and Avidity Biosciences, Inc. (RNA). Click either name above to swap in a different company.

Greenland Technologies Holding Corp. is the larger business by last-quarter revenue ($23.9M vs $12.5M, roughly 1.9× Avidity Biosciences, Inc.). Greenland Technologies Holding Corp. runs the higher net margin — -6.6% vs -1398.3%, a 1391.7% gap on every dollar of revenue. On growth, Avidity Biosciences, Inc. posted the faster year-over-year revenue change (434.0% vs 23.4%). Over the past eight quarters, Avidity Biosciences, Inc.'s revenue compounded faster (138.5% CAGR vs 2.5%).

Greenland Technologies Holding Corp is a specialized developer and manufacturer of electric industrial vehicles, lithium-ion drivetrain systems and industrial clean energy solutions. Its core products include electric forklifts and electric construction equipment components, serving logistics, construction and industrial customers across North America and Asia Pacific.

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

GTEC vs RNA — Head-to-Head

Bigger by revenue
GTEC
GTEC
1.9× larger
GTEC
$23.9M
$12.5M
RNA
Growing faster (revenue YoY)
RNA
RNA
+410.7% gap
RNA
434.0%
23.4%
GTEC
Higher net margin
GTEC
GTEC
1391.7% more per $
GTEC
-6.6%
-1398.3%
RNA
Faster 2-yr revenue CAGR
RNA
RNA
Annualised
RNA
138.5%
2.5%
GTEC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
GTEC
GTEC
RNA
RNA
Revenue
$23.9M
$12.5M
Net Profit
$-1.6M
$-174.4M
Gross Margin
35.4%
Operating Margin
-0.1%
-1513.5%
Net Margin
-6.6%
-1398.3%
Revenue YoY
23.4%
434.0%
Net Profit YoY
-120.8%
-117.0%
EPS (diluted)
$-0.11
$-1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GTEC
GTEC
RNA
RNA
Q4 25
$23.9M
Q3 25
$23.4M
$12.5M
Q2 25
$21.7M
$3.8M
Q1 25
$21.7M
$1.6M
Q4 24
$19.4M
$3.0M
Q3 24
$18.8M
$2.3M
Q2 24
$23.0M
$2.0M
Q1 24
$22.7M
$3.5M
Net Profit
GTEC
GTEC
RNA
RNA
Q4 25
$-1.6M
Q3 25
$5.7M
$-174.4M
Q2 25
$-3.2M
$-157.3M
Q1 25
$4.0M
$-115.8M
Q4 24
$7.6M
$-102.3M
Q3 24
$-684.4K
$-80.4M
Q2 24
$4.7M
$-70.8M
Q1 24
$2.5M
$-68.9M
Gross Margin
GTEC
GTEC
RNA
RNA
Q4 25
35.4%
Q3 25
32.4%
Q2 25
26.5%
Q1 25
30.7%
Q4 24
26.6%
Q3 24
26.4%
Q2 24
29.4%
Q1 24
24.9%
Operating Margin
GTEC
GTEC
RNA
RNA
Q4 25
-0.1%
Q3 25
21.6%
-1513.5%
Q2 25
-10.7%
-4448.7%
Q1 25
22.2%
-8360.9%
Q4 24
19.4%
-4069.6%
Q3 24
15.5%
-4200.9%
Q2 24
17.3%
-4040.4%
Q1 24
8.5%
-2178.6%
Net Margin
GTEC
GTEC
RNA
RNA
Q4 25
-6.6%
Q3 25
24.5%
-1398.3%
Q2 25
-14.8%
-4089.3%
Q1 25
18.5%
-7360.0%
Q4 24
39.2%
-3439.5%
Q3 24
-3.6%
-3441.7%
Q2 24
20.2%
-3461.8%
Q1 24
11.0%
-1943.4%
EPS (diluted)
GTEC
GTEC
RNA
RNA
Q4 25
$-0.11
Q3 25
$0.33
$-1.27
Q2 25
$-0.20
$-1.21
Q1 25
$0.29
$-0.90
Q4 24
$0.56
$-0.80
Q3 24
$-0.05
$-0.65
Q2 24
$0.34
$-0.65
Q1 24
$0.18
$-0.79

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GTEC
GTEC
RNA
RNA
Cash + ST InvestmentsLiquidity on hand
$32.2M
$350.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$72.9M
$1.9B
Total Assets
$115.8M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GTEC
GTEC
RNA
RNA
Q4 25
$32.2M
Q3 25
$33.0M
$350.2M
Q2 25
$23.1M
$243.9M
Q1 25
$20.2M
$254.2M
Q4 24
$25.2M
$219.9M
Q3 24
$24.7M
$370.2M
Q2 24
$22.6M
$575.8M
Q1 24
$18.8M
$471.4M
Stockholders' Equity
GTEC
GTEC
RNA
RNA
Q4 25
$72.9M
Q3 25
$75.4M
$1.9B
Q2 25
$69.2M
$1.2B
Q1 25
$64.6M
$1.3B
Q4 24
$60.2M
$1.4B
Q3 24
$57.1M
$1.5B
Q2 24
$56.3M
$1.2B
Q1 24
$51.9M
$830.9M
Total Assets
GTEC
GTEC
RNA
RNA
Q4 25
$115.8M
Q3 25
$123.4M
$2.1B
Q2 25
$123.6M
$1.4B
Q1 25
$118.6M
$1.5B
Q4 24
$115.6M
$1.6B
Q3 24
$127.5M
$1.6B
Q2 24
$126.8M
$1.3B
Q1 24
$139.2M
$951.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GTEC
GTEC
RNA
RNA
Operating Cash FlowLast quarter
$7.8M
$-156.2M
Free Cash FlowOCF − Capex
$-156.9M
FCF MarginFCF / Revenue
-1257.6%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-592.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GTEC
GTEC
RNA
RNA
Q4 25
$7.8M
Q3 25
$8.3M
$-156.2M
Q2 25
$-1.7M
$-199.7M
Q1 25
$1.2M
$-124.8M
Q4 24
$4.4M
$-99.9M
Q3 24
$6.1M
$-65.6M
Q2 24
$11.3M
$-65.0M
Q1 24
$-8.4M
$-70.4M
Free Cash Flow
GTEC
GTEC
RNA
RNA
Q4 25
Q3 25
$8.0M
$-156.9M
Q2 25
$-203.0M
Q1 25
$1.2M
$-128.6M
Q4 24
$-103.8M
Q3 24
$5.8M
$-67.3M
Q2 24
$-65.5M
Q1 24
$-9.6M
$-71.3M
FCF Margin
GTEC
GTEC
RNA
RNA
Q4 25
Q3 25
34.2%
-1257.6%
Q2 25
-5277.1%
Q1 25
5.7%
-8174.3%
Q4 24
-3491.0%
Q3 24
30.9%
-2881.8%
Q2 24
-3204.6%
Q1 24
-42.3%
-2012.3%
Capex Intensity
GTEC
GTEC
RNA
RNA
Q4 25
Q3 25
1.1%
5.7%
Q2 25
86.9%
Q1 25
0.1%
238.6%
Q4 24
131.7%
Q3 24
1.2%
72.9%
Q2 24
26.0%
Q1 24
5.2%
25.8%
Cash Conversion
GTEC
GTEC
RNA
RNA
Q4 25
Q3 25
1.44×
Q2 25
Q1 25
0.31×
Q4 24
0.57×
Q3 24
Q2 24
2.44×
Q1 24
-3.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GTEC
GTEC

Transmission Boxes For Forklift$23.1M97%
Other$758.3K3%

RNA
RNA

Segment breakdown not available.

Related Comparisons